33 /100
MEDIUM RISK
Score updated Jul 13, 2026

KRMD — KORU Medical Systems, Inc. Dilution Risk Tracker

Track KRMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KRMD — Get alerts when the score changes →

As of July 13, 2026, KORU Medical Systems, Inc. (KRMD) has a DilutionWatch DilutionScore of 33/100, rated MEDIUM dilution risk. KORU Medical Systems, Inc. has a market capitalization of $186.49M, 45.93M shares outstanding, 91 institutional holders tracked. Key dilution vectors include approximately 20 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
25
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for KRMD.
🔔 Track KRMD — Get forecast alerts →

💹 Market Data

Market Cap$186.49M
Shares Outstanding45.93M
Float28.34M
Cash$8.77M
Debt$348.4K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 12.3% shares (2026Q1 vs prior)
91 institutional holders · 23.60M shares
#1 First Light Asset Management, LLC 3.77M shares
#2 Topline Capital Management, LLC 3.51M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.37M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest678.5K
Days to Cover3.0
% of Float2.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for KRMD Shareholders

KORU Medical Systems, Inc. (KRMD) has a DilutionScore of 33/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for KRMD shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for KRMD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for KRMD alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track KRMD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KRMD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for KRMD
📊 KRMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KRMD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.